The phosphorothioate backbone modification
(PS) is one of the most
widely used chemical modifications for enhancing the drug-like properties
of nucleic acid-based drugs, including antisense oligonucleotides
(ASOs). PS-modified nucleic acid therapeutics show improved metabolic
stability from nuclease-mediated degradation and exhibit enhanced
interactions with plasma, cell-surface, and intracellular proteins,
which facilitates their tissue distribution and cellular uptake in
animals. However, little is known about the structural basis of the
interactions of PS nucleic acids with proteins. Here, we report a
crystal structure of the DNA-binding domain of a model ASO-binding
protein PC4, in complex with a full PS 2′-OMe DNA gapmer ASO.
To our knowledge this is the first structure of a complex between
a protein and fully PS nucleic acid. Each PC4 dimer comprises two
DNA-binding interfaces. In the structure one interface binds the 5′-terminal
2′-OMe PS flank of the ASO, while the other interface binds
the regular PS DNA central part in the opposite polarity. As a result,
the ASO forms a hairpin-like structure. ASO binding also induces the
formation of a dimer of dimers of PC4, which is stabilized by base
pairing between homologous regions of the ASOs bound by each dimer
of PC4. The protein interacts with the PS nucleic acid through a network
of electrostatic and hydrophobic interactions, which provides insights
into the origins for the enhanced affinity of PS for proteins. The
importance of these contacts was further confirmed in a NanoBRET binding
assay using a Nano luciferase tagged PC4 acting as the BRET donor,
to a fluorescently conjugated ASO acting as the BRET acceptor. Overall,
our results provide insights into the molecular forces that govern
the interactions of PS ASOs with cellular proteins and provide a potential
model for how these interactions can template protein–protein
interactions causative of cellular toxicity.